TITLE

THE RATIONAL USE OF VASODILATING AGENTS IN CHRONIC PERIPHERAL ARTERIAL AND ARTERIOLAR VASCULAR DISORDERS

AUTHOR(S)
Sherber, Daniel A.
PUB. DATE
January 1963
SOURCE
Angiology;Jan1963, Vol. 14 Issue 1, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Review of the pharmacology of vasodilating drugs would indicate that the most effective agents would be those acting directly on the smooth muscle of the blood vessels. This is so because such action is spasmolytic in character and in therapeutic doses does not block reflex vasomotor activity. Theoretically, such drugs should be free of any vascular side effects. A 5-year experience with cyclandelate (Cyclospasmol) bears this out. Of 137 patients with peripheral vascular disease treated with this drug, 80 per cent or 104 patients obtained good to moderate relief of their peripheral arterial insufficiency. Three women with Raynaud's disease had good to moderate response, and three out of four patients with thromboangiitis obliterans had a similar reaction. The dose used for 132 patients was 800 mg per day in divided dose. Our experience would indicate that patients who do not respond to 1600 mg per day will not react to larger doses. In no instances were any untoward effects of the drug noted even after 5 years. Treatment failure was most frequent in the oldest age group and in those patients with the longest history of vascular insufficiency. This would indicate that successful drug therapy is possible only when there are sufficient vessels capable of responding.
ACCESSION #
16395551

 

Related Articles

  • VASODILATORS AND THE USE OF CYCLOSPASMOL IN PERIPHERAL VASCULAR DISEASE. Mahl, Murray M. // Angiology;Sep1961, Vol. 12 Issue 9, p432 

    Cyclandelate is a useful general vasodilator for the treatment of peripheral diseases, with remarkable lack of the side effects. It is beneficial in arteriosclerosis obliterans and in thromboangitis obliterans, especially where concomitant coronary or cerebral disease or peptic ulcer is present....

  • CLINICAL EXPERIENCES WITH ISOXSUPRINE. Clarkson, I. S.; Le Pere, D. M. // Angiology;Jun1960 Part 1, Vol. 11 Issue 3, p190 

    With strictly a clinical office approach, isoxsuprine was used in the treatment of 100 patients with peripheral vascular disorders. Definite clinical improvement was obtained in 89 per cent of these patients. In our hands, isoxsuprine was found to be easy to administer, devoid of side effects in...

  • Protective Effects of Propranolol on the Exercise-Induced Reduction of Blood Flow in Arteriopathic Patients. Brevetti, Gregorio; Chiariello, Massimo; Rengo, Franco; Lavecchia, Giuseppe; Paudice, Giampaolo; Condorelli, Mario // Angiology;Oct1979, Vol. 30 Issue 10, p696 

    The vascular steal phenomenow, that is, the shunting of blood from ischemic to normally perfused areas, is commonly observed during exercise in the affected limbs of patients with peripheral arterial insufficiency. Propranolol was administered to 18 arteriopathic patients before the exercise to...

  • Effect of Ticlopidine on the Cutaneous Circulation in Peripheral Vascular Disease. Qian, Shuixian; Iwai, Takehisa // Angiology;Aug1993, Vol. 44 Issue 8, p627 

    To assess the effect of ticlopidine on the cutaneous circulation, 25 patients with lower limb ischemia were investigated just before and at two hours after being given a 200 mg oral dose of ticlopidine. The transcutaneous partial pressure of oxygen (PtcO2) and the skin temperature were...

  • THE APPLICATION OF BENZAZOLINE HCI BY MEANS OF ION TRANSFER. Dacso, Michael M.; Grynbaum, Bruce B. // Angiology;Apr1954, Vol. 5 Issue 2, p76 

    1. It was proven experimentally that benzazoline HCl (Priscoline®) will penetrate the human skin under the positive pole of galvanic current applied by the customary ion transfer technique. 2. Empirically, a 10 per cent concentration both in aqueous and ointment form was found the most...

  • Informatics applied to pharmacovigilance: Future perspectives. Menniti, Michele; Menniti, Annamaria; Patanè, Marinella; Esposito, Stefania; Giofrè, Chiara; Aiello, Rossana; Russo, Emilio // Journal of Pharmacology & Pharmacotherapeutics;Dec2013 Supplement 1, Vol. 4 Issue 5, p43 

    Spontaneous adverse drugs reaction (ADRs) reporting represents a precious resource for control and information about the drug's safety and pharmacovigilance. The current reporting system is mainly based on handwritten forms and later manually loaded into a national electronic database by few...

  • Alemtuzumab.  // Reactions Weekly;9/22/2007, Issue 1170, p7 

    The article describes the case of a 68-year-old man who experienced acute transformation of cutaneous T cell lymphoma during treatment with alemtuzumab. He was given ganciclovir for 7 days, followed by valganciclovir. His fever was resolved and the cytomegalovirus (CMV) viraemia became negative...

  • Azathioprine.  // Reactions Weekly;9/22/2007, Issue 1170, p10 

    The article describes the case of a man receiving azathioprine for Crohn's disease who developed peliosis hepatis, portal hypertension and cholestatic hepatitis after three episodes of alcohol binging. Azathioprine was discontinued and he received corticosteroid pulse therapy. Results of his...

  • Digoxin interaction.  // Reactions Weekly;3/12/2005, Issue 1042, p10 

    Discusses research being done on the interaction between clarithromycin and digoxin in patients with end-stage renal disease. Reference to a study by S. Hirata, S. Izumi, T. Furukubo published in the January 2005 issue of the "International Journal of Clinical Pharmacology and Therapeutics";...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics